Investigating the causal link between metformin and lung cancer risk: a two-sample mendelian randomization analysis.

Abstract excerpt

Lung cancer ranks as the most prevalent malignancy worldwide. Current studies have found that metformin is associated with the occurrence of lung cancer. Nevertheless, these results are not consistent. This study seeks to explore the potential causal connection among them utilizing a two-sample Mendelian randomization (MR) approach. Genome-wide association studies (GWAS) databases were subjected to data mining in...

Topics

Join the communities discussing this publication.

• Genome-Wide Association Study
• Hypoglycemic Agents
• Lung Neoplasms
• Mendelian Randomization Analysis
• Metformin